YY/T 0879.2-2015 English PDFUS$209.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email. YY/T 0879.2-2015: Test for hypersensitivity of medical devices. Part 2: Marine Local Lymph Node Assay (LLNA): BrdU-ELISA method Status: Valid
Basic dataStandard ID: YY/T 0879.2-2015 (YY/T0879.2-2015)Description (Translated English): Test for hypersensitivity of medical devices. Part 2: Marine Local Lymph Node Assay (LLNA): BrdU-ELISA method Sector / Industry: Medical Device & Pharmaceutical Industry Standard (Recommended) Classification of Chinese Standard: C30 Classification of International Standard: 11.040.01 Word Count Estimation: 10,153 Date of Issue: 2015-03-02 Date of Implementation: 2016-01-01 Quoted Standard: GB/T 16886.1; GB/T 16886.2; GB/T 16886.10; GB/T 16886.12 Regulation (derived from): The State Food and Drug Administration Announcement 2015 No. 8 Issuing agency(ies): State Food and Drug Administration Summary: This Standard specifies the test methods for medical device or material sensitization reactions. This section guinea pig sensitization test is expected to provide an alternative method has certain limitations prior to use, the applicability of the method should be confirmed. YY/T 0879.2-2015: Test for hypersensitivity of medical devices. Part 2: Marine Local Lymph Node Assay (LLNA): BrdU-ELISA method---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order. Test for hypersensitivity of medical devices.Part 2. Marine Local Lymph Node Assay (LLNA). BrdU-ELISA method ICS 11.040.01 C30 People's Republic of China pharmaceutical industry standards Medical Devices sensitization test Part 2. The local lymph node assay in mice (LLNA) BrdU-ELISA method Part 2. MurineLocalLymphNodeAssay (LLNA). BrdU-ELISAmethod Issued on. 2015-03-02 2016-01-01 implementation China Food and Drug Administration released ForewordYY/T 0879 "Medical Devices sensitization test" intended to divide part of the publication, currently plans to release the following components. --- Part 1. local lymph node assay (LLNA) mouse; --- Part 2. local lymph node assay (LLNA) mouse BrdU-ELISA method. This section YY/T Section 20879 of. This section drafted in accordance with GB/T 1.1-2009 given rules. Please note that some of the content of this document may involve patents. Release mechanism of the present document does not assume responsibility for the identification of these patents. This part is proposed by the China Food and Drug Administration. This part of the National Biological evaluation of medical devices Standardization Technical Committee (SAC/TC248) centralized. This section drafted by. State Food and Drug Administration Jinan Medical Device Quality Supervision and Inspection Center, the State Food and Drug Pipe Authority Peking University Medical Device Quality Supervision and Inspection Center, Sichuan biomaterials and medical devices products inspection center. This section drafters. Sun Likui, INVENTORY, Lin Hong, Zhang Jin, Yuan Tun, Jiali Fang.IntroductionYY/T 0879.1 in the use of radioactive thymidine incorporation of uridine or method to detect sensitization potential of medical devices, It can be used to partially replace GB/T 16886.10 specified in the guinea pig sensitization test. But in the purchase, use or waste radioactive material handling Difficult areas, use of the test subject to certain restrictions. This part is LLNA method improvement, non-radioactive, and has After international independent scientific assessment team confirmed the blind, evaluation, and recommended as there are some limitations of the test for identifying skin sensitizing substance method. And YY/T 0879.1 similar to this part of the study of the induction phase of skin sensitization and provides a suitable dose-response assessment of quantitative data. And may not be used for radioactive labeled DNA, eliminating occupational exposure and radioactive waste disposal problems. Meanwhile, the ratio of part Skin sensitization test using guinea pigs in an amount less inspire challenges induction phase of skin sensitization reactions inside do not need. And not like the guinea pig The maximum dose tested as an adjuvant to reduce the suffering of animals. More in line with GB/T 16886.2 requirements. This section does not necessarily apply to all of the test substance. For example, when some of the metal test, found that some skin irritation because the surface contains (Such as surfactant) and this substance is soluble, it will make the results were false positive. In addition, the test substance or containing certain categories Have indicated that substance as a potential confounders functional groups may also require the use of guinea pig sensitization test. Meanwhile, YY/T 0879.1 identified A limitation also applies to this section. Before using this section, the laboratory should consider all available information on the test substance, including The name and the chemical structure of the test substance including physical and chemical properties, and any other in vivo or in vitro toxicity test results and the number of structurally related toxicology According to determine whether this section applies to the test substance, and help for the test substance dose selection. In addition, when the stimulation index (SI) is between 1.6 and 1.9 should be considered critical positive possibilities. However, since the phase The same data set to set the SI value and used to calculate the ability to identify the test results described may overestimate the actual recognition. Medical Devices sensitization test Part 2. The local lymph node assay in mice (LLNA) BrdU-ELISA method1 ScopeYY/T 0879 gives this part of the medical device or test methods for materials sensitization reactions. This section is expected to provide an alternative method to the guinea pig sensitization test, with certain limitations, before use of the method should be applicable Of confirmation.2 Normative referencesThe following documents for the application of this document is essential. For dated references, only the dated version suitable for use herein Member. For undated references, the latest edition (including any amendments) applies to this document. GB/T 16886.1 Biological evaluation of medical devices - Part 1. Evaluation of the risk management process and Test GB/T 16886.2 Biological evaluation of medical devices - Part 2. Animal welfare requirements GB/T 16886.10 Biological evaluation of medical devices - Part 10. irritation and delayed-type hypersensitivity test GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference materials3 Terms and DefinitionsGB/T 16886.1, terms and definitions GB/T 16886.2 and GB/T 16886.10 defined apply to this document.4 Test principleLymphocyte proliferation in the medical device sensitizing agent may be induced sites draining lymph nodes. The proliferation sensitizing agent used The dosage and sensitizing potential proportional to, thus providing a simple access method for quantitative measurement of sensitization. BrdU is a thymidine Glycoside analogs may be incorporated into the DNA of proliferating cells. Test methods for measuring animal ear by enzyme-linked immunosorbent assay (ELISA) The amount of BrdU incorporated within the draining lymph nodes to indicate the increase in the number of proliferating cells, proliferation and use than the average volume of the test group and the control group (SI) to assess proliferation can be measured to determine the allergenic potential of substances. Description 5 Test Method 5.1 Selection of animal species The choice of test animal species belong to a mouse. CBA/JN strain is most recommended. No adult should use birth and did not become pregnant female Of CBA/JN mice aged 8 weeks to 12 weeks of age. In the beginning of the experiment, body weight should not exceed ± 20% of average weight. When there is sufficient In this test, the data confirm the absence of strain and/or gender-specific differences can also select a different strain or male animals, such as BALB/c strain. ......Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of YY/T 0879.2-2015_English be delivered?Answer: Upon your order, we will start to translate YY/T 0879.2-2015_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time.Question 2: Can I share the purchased PDF of YY/T 0879.2-2015_English with my colleagues?Answer: Yes. The purchased PDF of YY/T 0879.2-2015_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to Sales@ChineseStandard.net. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay. |
